PUBLISHER: The Business Research Company | PRODUCT CODE: 1946662
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946662
Ophthalmic viscoelastic devices (OVDs) are gel-such as substances utilized in specific eye surgeries to establish and maintain intraocular space, safeguard delicate eye structures, and aid in surgical maneuvers. These substances typically possess a clear, viscous, and elastic nature, mimicking the properties of natural fluids found within the eye.
The primary categories of OVDs are cohesive ophthalmic viscoelastics and dispersive ophthalmic viscoelastics. Cohesive ophthalmic viscoelastics are highly viscous and cohesive, maintaining their form as a single mass rather than dispersing within the eye. They are predominantly employed in cataract surgery but also find application in procedures such as glaucoma surgery, corneal transplant, and vitreoretinal surgery. These substances are utilized by various entities, including hospitals, ophthalmology clinics, and similar medical facilities.
Tariffs are impacting the ophthalmic viscoelastic devices market by increasing costs of imported pharmaceutical-grade polymers, sterilization materials, medical packaging, and precision manufacturing equipment. Hospitals and ophthalmology clinics in North America and Europe are most affected due to dependence on imported raw materials and specialized production inputs, while Asia-Pacific faces pricing pressure on exports. These tariffs are increasing production costs and influencing pricing strategies for surgical consumables. However, they are also encouraging localized manufacturing, regional sourcing of biomaterials, and long-term investments in domestic ophthalmic device production capabilities.
The ophthalmic viscoelastic devices market research report is one of a series of new reports from The Business Research Company that provides ophthalmic viscoelastic devices market statistics, including ophthalmic viscoelastic devices industry global market size, regional shares, competitors with a ophthalmic viscoelastic devices market share, detailed ophthalmic viscoelastic devices market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic viscoelastic devices industry. This ophthalmic viscoelastic devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ophthalmic viscoelastic devices market size has grown steadily in recent years. It will grow from $2.72 billion in 2025 to $2.85 billion in 2026 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to increasing prevalence of cataract surgeries, growing aging population, rising adoption of intraocular surgical procedures, expansion of ophthalmology clinics, improved access to eye care services.
The ophthalmic viscoelastic devices market size is expected to see strong growth in the next few years. It will grow to $3.47 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increasing demand for premium ophthalmic surgical outcomes, rising focus on complication reduction, expansion of advanced ophthalmic surgery centers, growing investments in eye care infrastructure, increasing adoption of innovative viscoelastic materials. Major trends in the forecast period include increasing adoption of advanced viscoelastic formulations, rising demand for dual-property ovds, growing focus on enhanced tissue protection, expansion of minimally invasive ophthalmic surgeries, improved shelf stability and biocompatibility profiles.
The rising number of ophthalmic surgeries is expected to drive growth in the ophthalmic viscoelastic devices (OVDs) market. Ophthalmic surgeries include procedures such as cataract extraction, corneal transplants, and retinal detachment repair. OVDs are essential in these surgeries, as their viscous and elastic properties help maintain space within the eye, protect delicate structures, facilitate surgical maneuvers, and provide clear visualization. This contributes to better surgical outcomes and reduces complications like tissue trauma and intraoperative issues. For example, in May 2023, the National Health Service England, a UK-based publicly funded healthcare system, reported that cataract surgery accounts for 6% of all surgeries, with over 450,000 procedures performed annually. Projections indicate a 25% increase by 2027 and a 50% rise by 2035 in cataract surgeries, highlighting the growing demand for OVDs.
Major companies in the ophthalmic viscoelastic devices market are focusing on technological innovations, such as line implant-free system solutions, to improve surgical precision and patient outcomes. Advanced line implant-free systems provide non-intrusive solutions that enhance surgical procedures without requiring implants. For example, in April 2023, Bausch + Lomb Corporation, a US-based eye health company, launched the StableVisc cohesive OVD and the TotalVisc Viscoelastic System. StableVisc maintains space in the anterior chamber, facilitating lens extraction and replacement, while the TotalVisc System combines StableVisc and ClearVisc, a dispersive OVD, to protect ocular tissue during surgery. Both products contain sodium hyaluronate and sorbitol, which laboratory studies show offer improved free radical scavenging, providing dual-action mechanical and chemical protection during ophthalmic procedures.
In January 2024, the Netherlands-based pharmaceutical company Nordic Group B.V. acquired Visant Medical, Inc. for an undisclosed sum. This acquisition allows Nordic Group B.V. to enhance its portfolio in the global ophthalmology market and expand its commercialization and development of specialized products across therapeutic areas within ophthalmology. Visant Medical, Inc., a U.S.-based company, focuses on the development of innovative medical devices for ophthalmic applications.
Major companies operating in the ophthalmic viscoelastic devices market are Altacor Ltd., Bausch Health Companies Inc., Bohus Biotech AB, Carl Zeiss Meditec AG, Haohai Biological Technology Co. Ltd., Johnson & Johnson Pvt. Ltd., Novartis International AG, Rumex International Corporation, Rayner Intraocular Lenses Limited, Aurolab, Alcon Inc., Beaver-Visitec International, Neu Micromed International Pvt. Ltd., Abbott Medical Optics, Maxigen Biotech Inc., Amring Pharmaceuticals Inc., Croma Pharma GmbH, Medicontur Medical Engineering Ltd., Rhein Medical Inc., MicroSurgical Technology, FCI Ophthalmics Inc., Hanita Lenses Ltd., HOYA Medical Singapore Pte. Ltd.
North America was the largest region in the ophthalmic viscoelastic devices market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global ophthalmic viscoelastic devices market report during the forecast period. The regions covered in the ophthalmic viscoelastic devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the ophthalmic viscoelastic devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The ophthalmic viscoelastic devices market consists of sales of cohesive OVDs, dispersive OVDs, and combined OVDs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ophthalmic Viscoelastic Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses ophthalmic viscoelastic devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ophthalmic viscoelastic devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ophthalmic viscoelastic devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.